This $6,510.02 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product, with a completion date of December 6, 2024.
Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, SPE2DB24D8001, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT Generation V Program, allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The current delivery order is one of many awarded under this larger contract vehicle. The contract does not have a set-aside designation.
Generated 3/6/25, 9:58 AM